United States cholesterol guidelines 2001

Expanded scope of intensive low-density lipoprotein-lowering therapy

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The new clinical guidelines of the US National Cholesterol Education Program (NCEP) were released in May 2001. These guidelines were published as the NCEP's Adult Treatment Panel (ATP) III report. They are derived from an extensive review of the emerging literature so as to provide an evidence-based report. Thanks to recent clinical trials of cholesterol-lowering therapy, it is possible to expand the scope of clinical management for both dietary and drug therapies. This expansion derives from a conclusive demonstration of efficacy, safety, and cost-effectiveness of therapies. This article will review briefly the major features of ATP III.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
Volume88
Issue number7 SUPPL. 2
StatePublished - Oct 11 2001

Fingerprint

LDL Lipoproteins
Cholesterol
Guidelines
Therapeutics
Cost-Benefit Analysis
Clinical Trials
Safety
Education
Drug Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{6c739f2ef074485b8a3ebed89b65373e,
title = "United States cholesterol guidelines 2001: Expanded scope of intensive low-density lipoprotein-lowering therapy",
abstract = "The new clinical guidelines of the US National Cholesterol Education Program (NCEP) were released in May 2001. These guidelines were published as the NCEP's Adult Treatment Panel (ATP) III report. They are derived from an extensive review of the emerging literature so as to provide an evidence-based report. Thanks to recent clinical trials of cholesterol-lowering therapy, it is possible to expand the scope of clinical management for both dietary and drug therapies. This expansion derives from a conclusive demonstration of efficacy, safety, and cost-effectiveness of therapies. This article will review briefly the major features of ATP III.",
author = "Grundy, {Scott M}",
year = "2001",
month = "10",
day = "11",
language = "English (US)",
volume = "88",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7 SUPPL. 2",

}

TY - JOUR

T1 - United States cholesterol guidelines 2001

T2 - Expanded scope of intensive low-density lipoprotein-lowering therapy

AU - Grundy, Scott M

PY - 2001/10/11

Y1 - 2001/10/11

N2 - The new clinical guidelines of the US National Cholesterol Education Program (NCEP) were released in May 2001. These guidelines were published as the NCEP's Adult Treatment Panel (ATP) III report. They are derived from an extensive review of the emerging literature so as to provide an evidence-based report. Thanks to recent clinical trials of cholesterol-lowering therapy, it is possible to expand the scope of clinical management for both dietary and drug therapies. This expansion derives from a conclusive demonstration of efficacy, safety, and cost-effectiveness of therapies. This article will review briefly the major features of ATP III.

AB - The new clinical guidelines of the US National Cholesterol Education Program (NCEP) were released in May 2001. These guidelines were published as the NCEP's Adult Treatment Panel (ATP) III report. They are derived from an extensive review of the emerging literature so as to provide an evidence-based report. Thanks to recent clinical trials of cholesterol-lowering therapy, it is possible to expand the scope of clinical management for both dietary and drug therapies. This expansion derives from a conclusive demonstration of efficacy, safety, and cost-effectiveness of therapies. This article will review briefly the major features of ATP III.

UR - http://www.scopus.com/inward/record.url?scp=0035845991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035845991&partnerID=8YFLogxK

M3 - Article

VL - 88

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7 SUPPL. 2

ER -